These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 24604164)
1. Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway. Yan GN; Yang L; Lv YF; Shi Y; Shen LL; Yao XH; Guo QN; Zhang P; Cui YH; Zhang X; Bian XW; Guo DY J Pathol; 2014 Sep; 234(1):11-22. PubMed ID: 24604164 [TBL] [Abstract][Full Text] [Related]
2. Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells. Uchida H; Arita K; Yunoue S; Yonezawa H; Shinsato Y; Kawano H; Hirano H; Hanaya R; Tokimura H J Neurooncol; 2011 Sep; 104(3):697-704. PubMed ID: 21380601 [TBL] [Abstract][Full Text] [Related]
3. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway. Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920 [TBL] [Abstract][Full Text] [Related]
4. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice]. Song WC; Fei XF; Dong J Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046 [TBL] [Abstract][Full Text] [Related]
6. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346 [TBL] [Abstract][Full Text] [Related]
7. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866 [TBL] [Abstract][Full Text] [Related]
9. Sialidase NEU4 is involved in glioblastoma stem cell survival. Silvestri I; Testa F; Zappasodi R; Cairo CW; Zhang Y; Lupo B; Galli R; Di Nicola M; Venerando B; Tringali C Cell Death Dis; 2014 Aug; 5(8):e1381. PubMed ID: 25144716 [TBL] [Abstract][Full Text] [Related]
10. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression. Gopinath S; Malla R; Alapati K; Gorantla B; Gujrati M; Dinh DH; Rao JS Carcinogenesis; 2013 Mar; 34(3):550-9. PubMed ID: 23222817 [TBL] [Abstract][Full Text] [Related]
11. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540 [TBL] [Abstract][Full Text] [Related]
12. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth. Di K; Linskey ME; Bota DA Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro. Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414 [TBL] [Abstract][Full Text] [Related]
15. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells. Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970 [TBL] [Abstract][Full Text] [Related]
16. Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. Wang Z; Wang B; Shi Y; Xu C; Xiao HL; Ma LN; Xu SL; Yang L; Wang QL; Dang WQ; Cui W; Yu SC; Ping YF; Cui YH; Kung HF; Qian C; Zhang X; Bian XW Oncogene; 2015 Mar; 34(11):1407-19. PubMed ID: 24704830 [TBL] [Abstract][Full Text] [Related]
17. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway. Yang W; Liu Y; Gao R; Yu H; Sun T Cancer Lett; 2018 Feb; 415():164-176. PubMed ID: 29222038 [TBL] [Abstract][Full Text] [Related]